Cannabidivarin (CBDv) is a lesser-known cannabinoid found in the cannabis plant. Research suggests that CBDv may have potential therapeutic benefits, particularly for its anti-epileptic and anti-nausea properties. Studies have shown that CBDv may help reduce seizures in individuals with epilepsy, making it a promising treatment option for those who do not respond well to traditional medications. Additionally, CBDv has been found to have anti-nausea effects, which could be beneficial for individuals undergoing chemotherapy or experiencing motion sickness. While more research is needed to fully understand the extent of CBDv’s benefits, early findings are promising and suggest that this cannabinoid may have a range of potential medical applications.